Research Highlights/News

2024 | 2023 | 2022 | 2021 | 2020

»  Look for consumer stories click here

2024

Research Highlights:

• CDMRP Funds Research to Support Service Members and Veterans with Multiple Sclerosis
• Glucagon-Like Peptide-1 Receptor Agonist as New Therapeutics for Multiple Sclerosis

2023

Research Highlights:

• Bioengineered Particles to Promote Regulatory T Cells and Modulate the Immune System in Transplantation and Multiple Sclerosis

2022

Press Releases:

• CDMRP-Funded Research Leads to FDA Breakthrough Device Designation for MS Blood Biomarker Test
  May 13, 2022

Research Highlights:

• Fitness Trackers and Smartphones Used to Predict Behavior Changes in People with Multiple Sclerosis During the COVID-19 Stay-at-Home Mandate
• Physical Telerehabilitation Program for Multiple Sclerosis Patients Improves Patients’ Quality of Life

2021

Research Highlights:

• Reduced Disease Severity Following Novel Angiotensin 1-7 Treatment in MS Mouse Model
• Imaging Measures Reflect Cognitive Changes Over Time in Multiple Sclerosis Patients
• Exercise Training, Metabolic Changes, and Symptoms in People with MS
• Exploring Remyelination in MS: Myelin, Metformin, and Mitochondria

2020

Research Highlights:

• Acceleration of Oligodendrocyte Maturation and Functional Remyelination in an MS Model Following Flavonoid Treatment
• The Role of Protein Deimination in Restoring Visual Function in MS Patients
• Differential Association of Age and Serum Neurofilament Light Chain in MS Patients
• Online Toolkit to Assist with Self-Management of MS Symptoms

Top of Page